PRM1 and prostate adenocarcinoma: Hence, a RT-PCR based approach was also used to clarify which promoters within the TBXA2R, namely Prm1 or Prm3, are regulating TPα and TPβ expression in human prostate tissue or in the prostate adenocarcinoma LNCaP and PC-3 cell lines.